← All themes Genomics & Gene Editing

Gene Therapy

Gene therapy delivers a working copy of a gene, or a correction to a faulty one, usually once and for life. Manufacturing the delivery vector is often harder than designing the therapy.

131 stocks

#	Name	Funds holding	Growth	Growth %	Fund value
76	DBTX 76 DELISTED Decibel Therapeutics, Inc. Common Stock DBTX	–	–	–	–
77	77 Precision BioSciences DTIL $166M	–	–	–	–
78	78 enGene Therapeutics ENGN $105M	–	–	–	–
79	79 Estrella Immunopharma ESLA $13.8M	–	–	–	–
80	80 FibroBiologics FBLG $6.73M	–	–	–	–
81	81 4D Molecular Therapeutics FDMT $674M	–	–	–	–
82	FRLN 82 DELISTED Freeline Therapeutics Holdings plc American Depositary Shares FRLN	–	–	–	–
83	83 DELISTED Generation Bio GBIO	–	–	–	–
84	84 CytoMed Therapeutics GDTC $10.3M	–	–	–	–
85	GMDA 85 DELISTED Gamida Cell Ltd. Ordinary Shares GMDA	–	–	–	–
86	86 Genenta Science GNTA $31.8M	–	–	–	–
87	GRCL 87 DELISTED Gracell Biotechnologies Inc. American Depositary Shares GRCL	–	–	–	–
88	GRML 88 Greenland Mines Ltd GRML $86.6M	–	–	–	–
89	89 Fractyl Health GUTS $54.1M	–	–	–	–
90	90 Immix Biopharma IMMX $706M	–	–	–	–
91	91 Immatics IMTX $1.07B	–	–	–	–
92	92 IN8bio INAB $11.8M	–	–	–	–
93	93 MiNK Therapeutics INKT $52.8M	–	–	–	–
94	94 INmune Bio INMB $44.4M	–	–	–	–
95	95 Century Therapeutics IPSC $250M	–	–	–	–
96	KRBP 96 DELISTED Kiromic BioPharma, Inc. Common Stock KRBP	–	–	–	–
97	97 Kyverna Therapeutics KYTX $351M	–	–	–	–
98	98 Legend Biotech LEGN $3.7B	–	–	–	–
99	LGVN 99 Longeveron LGVN $5.52M	–	–	–	–
100	100 Lunai Bioworks LNAI $4.05M	–	–	–	–